Effects of nimesulide on kainate-induced in vitro oxidative damage in rat brain homogenates

BMC Pharmacology

Volumn 3, Issue , 2003, Pages

  Candelario Jalil, Eduardo ^a   León, Olga Sonia ^a  

^a UNIVERSITY OF HAVANA   (Cuba)

Author keywords

Cyclooxygenase 2; Kainate excitotoxicity; Neuroprotection; Nimesulide; Oxidative stress

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; KAINIC ACID; MALONALDEHYDE; NIMESULIDE; SCAVENGER; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 2642587413     PISSN: 14712210     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2210-3-7     Document Type: Article

References (34)

1. Davis R and Brogden RN: Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy Drugs 1994, 48:431-454.
2. Famaey JP: In vitro and in vivo pharmacological evidence of selective cyclooxygense-2 inhibition by nimesulide: an overview Inflamm Res 1997, 46:437-446.
3. Rabasseda X: Nimesulide: a selective cyclooxygenase 2 inhibitor antiinflammatory dru Drugs Today 1996, 32(Suppl 1):1-23.
4. Rossoni G, Berti F, Buschi LM and Della Bella D: New data concerning the anaphylactic and antihistaminic activity of nimesulid Drugs 1993, 46(Suppl 1):22-28.
5. Ferreira SH: The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesic Drugs 1993, 46(Suppl 1):1-9.
6. Tool AT and Verhoeven AJ: Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate Arzneimittel Forschung 1995, 45:1110-1114.
7. Verhoeven AJ, Tool AT, Kuijpers TW and Roos D: Nimesulide inhibits platelet-activating factor synthesis in activated human neutrophil Drugs 1993, 46(Suppl 1):52-58.
8. Bevilacqua M, Vago T, Baldi G, Renesto E, Dallegri F and Norbiato G: Nimesulide decreases superoxide production by inhibiting phosphodiesterase type IV Eur J Pharmacol 1994, 268:415-423.
9. Ottonello L, Dapino P, Pastorino G, Montagnani G, Gatti F, Guidi G and Dallegri F: Nimesulide as a downregulator of the activity of the neutrophil myeloperoxidase pathway. Focus on the histoprotective potential of the drug during inflammatory processes Drugs 1993, 46(Suppl 1):29-33.
10. Capecchi PL, Ceccatelli L, Beermann U, Laghi Pasini F and Di Perri T: Inhibition of neutrophil function in vitro by nimesulide. Preliminary evidence of an adenosine-mediated mechanism Arzneimittel Forschung 1993, 43:992-996.
11. Maffei-Facino R, Carini M, Aldini G, Saibene L and Morelli R: Differential inhibition of superoxide, hydroxyl and peroxyl radicals by nimesulide and its main metabolite 4-hydroxynimesulid Arzneimittel Forschung 1995, 45:1102-1109.
12. Coyle JT and Schwarcz R: Lesion of striatal neurons with kainic acid provides a model for Huntington's chore Nature 1976, 263:244-246.
13. Coyle JT: Neurotoxic action of kainic acid. Short revie J Neurochem 1983, 41:1.
14. Dutrait N, Culcasi M, Cazevieille C, Pietri S and Müller A: Calcium-dependent free radical generation in cultured retinal neurons injured by kainate Neurosci Lett 1995, 198:13-16.
15. Dykens JA, Stern A and Trenkner E: Mechanisms of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury J Neurochem 1987, 49:1222-1228.
16. Sun AY, Cheng Y, Bu Q and Oldfield F: The biochemical mechanism of the excitotoxicity of kainic acid Mol Chem Neuropathol 1992, 17:51-63.
17. Bondy SC and Lee DK: Oxidative stress induced by glutamate receptor agonists Brain Res 1993, 610:229-233.
18. Bose R, Schnell L, Pinsky C and Zitko V: Effects of excitotoxins on free radical indices in mouse brain Toxicol Lett 1992, 60:211-219.
19. Candelario-Jalil E, Ajamieh HH, Sam S, Martínez G and León OS: Nimesulide limits kainate-induced oxidative damage in the rat hippocampus Eur J Pharmacol 2000, 390:295-298.
20. Candelario-Jalil E, Alvarez D, González-Falcón A, García-Cabrera M, Martínez-Sánchez G, Merino N, Giuliani A and León OS: Neuroprotective efficacy of nimesulide against hippocampal neuronal damage following transient forebrain ischemia Eur J Pharmacol 2002, 453:189-195.
21. Halliwell B and Gutteridge JMC: Oxygen radicals and the nervous syste Trends Neurosci 1985, 8:22-29.
22. Puttfarcken PS, Getz RL and Coyle JT: Kainic acid-induced lipid peroxidation: protection with butylated hydroxytoluene and U7851F in primary cultures of cerebellar granule cells Brain Res 1993, 624:223-232.
23. Hamer I, Wattiaux R and Wattiaux CS: Deleterious effects of xanthine oxidase on rat liver endothelial cells after ischemia/ reperfusion Biochim Biophys Acta 1995, 1269:145-152.
24. Hurley SD, Olschowka JA and O'Banion MK: Cyclooxygenase inhibition as a strategy to ameliorate brain injury J Neurotrauma 2002, 19:1-15.
25. Sanz O, Estrada A, Ferrer I and Planas AM: Differential cellular distribution and dynamics of HSP70, cyclooxygenase-2, and c-Fos in the rat brain after transient focal ischemia or kainic acid Neuroscience 1997, 80:221-232.
26. Sandhya TL, Ong WY, Horrocks LA and Farooqui AA: A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesions Brain Res 1998, 788:223-231.
27. Hashimoto K, Watanabe K, Nishimura T, Iyo M, Shirayama Y and Minabe Y: Behavioral changes and expression of heat shock protein HSP-70 mRNA, brain-derived neurotrophic factor mRNA, and cyclooxygenase-2 mRNA in rat brain following seizures induced by systemic administration of kainic acid Brain Res 1998, 804:212-223.
28. Tocco G, Freire-Moar J, Schreiber SS, Sakhi SH, Aisen PS and Pasinetti GM: Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease Exp Neurol 1997, 144:339-349.
29. Facino RM, Carini M and Aldini G: Antioxidant activity of nimesulide and its main metabolites Drugs 1993, 46(Suppl 1):15-21.
30. Maffei-Facino R, Carini M, Aldini G, Saibene L and Macciocchi A: Antioxidant profile of nimesulide, indomethacin and diclofenac in phosphatidylcholine liposomes (PCL) as membrane model Int J Tissue React 1993, 15:225-234.
31. Melchiorri D, Reiter RJ, Chen LD, Sewerynek E and Nistico G: Melatonin affords protection against kainate-induced in vitro lipid peroxidation in brain Eur J Pharmacol 1996, 305:239-242.
32. Esterbauer H and Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonena Meth Enzymol 1990, 186:407-421.
33. Sedlak J and Lindsay RH: Estimation of total protein-bound and nonprotein sulfhydryl groups in tissue with Ellman's reagent Anal Biochem 1968, 25:192-205.
34. Spector T: Refinement of the Coomassie Blue method of protein quantification Anal Biochem 1978, 86:142-146.